MedShape, Inc. appears in FDA device records as an applicant for Class II orthopedic bone fixation devices reviewed under regulation 21 CFR 888.3040, product code HWC. The supplied filing sample contains one 510(k) record, K260995 for the DynaNail Helix Fixation System, decided substantially equivalent on September 23, 2026, after a March 26, 2026 receipt date. A separate FDA letter addresses K254110, a submission naming several DynaNail and DynaClip variants. The company's documented identity here is regulatory rather than commercial: the filings describe device families and predicate lineage, not sales, customers or clinical results. [1][2][5]

The K260995 DynaNail Helix clearance

K260995 covers the DynaNail Helix Fixation System, listed under product code HWC with the device description "Screw, Fixation, Bone," Class II, regulation number 888.3040, and orthopedic advisory committee review. The FDA record shows a Traditional clearance, a Summary statement, no third-party review, and a decision of Substantially Equivalent dated September 23, 2026. The applicant is recorded as MedShape, Inc. at 1575 Northside Dr., Suite 440, Atlanta, GA 30318, with Lauren Livsey as contact. [1]

The supplied collection snapshot links one 510(k) record to this company, and that single record carries a Substantially Equivalent decision. The record sample contains the same one entry, so the sample decision count and the collection decision count both show one SESE filing. These figures describe the supplied filings only and do not represent total company submissions, sales or safety performance. [1]

The K254110 family submission

An FDA letter dated March 18, 2026 responds to MedShape, Inc. regarding K254110, naming DynaNail Mini, DynaNail Hybrid, DynaNail Helix, DynaClip, DynaClip Forte, DynaClip Delta and DynaClip Quattro. The letter lists regulation number 21 CFR 888.3040, regulation name Smooth Or Threaded Metallic Bone Fixation Fastener, Class II, and product codes HWC, HTN, JDS and JDR. [2]

The same letter identifies predicate devices and their clearance dates, including DynaNail Mini as primary predicate under K182677 cleared February 14, 2019; DynaNail Hybrid under K203381 and K240530; DynaNail Helix under K203595 cleared January 4, 2022; DynaClip under K181781; DynaClip Forte under K193305; and DynaClip Delta and Quattro under K220812. It also notes the DynaNail TTC Fusion System, K250628, as a reference device. A separate FDA database page for K254110 records receipt on December 19, 2025, a decision date of March 18, 2026, and a Substantially Equivalent decision. [2][5]

Device components and stated technology

The DynaNail Helix Instructions for Use describe a system consisting of a DynaNail Helix Threaded Bone Fastener and a DynaNail Helix Washer, implanted with Ancillary Surgical Instruments. The fastener is manufactured from nickel titanium alloy and titanium alloy (Ti6Al-4V ELI) and is available in multiple lengths; the washer is manufactured from titanium alloy (Ti6Al-4V ELI). The document carries a federal restriction limiting sale to or on the order of a physician and lists MedShape, Inc. at the Atlanta address. [3]

Enovis product material states that the DynaNail Helix uses patented pseudoelastic NiTiNOL technology and a threaded design, and describes continuous compression that adapts to bone resorption and joint settling. Those characterizations are attributed to the publisher of that page. The same page includes a disclaimer directing readers to a healthcare professional for treatment information. [4]

Applicant identity and brand context

The FDA records identify MedShape, Inc. as the legal applicant on K260995 and as the addressee of the K254110 letter, with the Atlanta filing address appearing in both. The Enovis-hosted Instructions for Use carries MedShape, Inc. contact details and states that DynaNail Helix is a trademark of MedShape, Inc., while the product page sits on the Enovis site. That placement does not by itself establish ownership, headquarters or a corporate parent relationship, which remain unknown from the public documents. [1][2][3][4]